InvestorsObserver
Sign Up Login

IBB Nasdaq Biotechnology Ishares ETF

$125.85 $0.00 (0.00%)
15 Minute Delayed Price Enable Real-Time Price
Add to Watchlist Compare
Overall

IBB Stock Analysis Overview

What this means: InvestorsObserver gives Nasdaq Biotechnology Ishares ETF (IBB) an overall rank of 38, which is below average. Nasdaq Biotechnology Ishares ETF is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. A rank of 38 means that 62% of stocks appear more favorable to our system.

Who this matters to: Overall Ranking is a comprehensive evaluation. It considers technical and fundamental factors and is a good starting point for evaluating a stock.

View Sample Report
Fundamental PREMIUM

IBB Fundamental Analysis

Who this matters to: The Fundamental Ranking considers the health of the underlying company. It is best used by longer-term buy-and-hold investors.

Upgrade to Premium to unlock Fundamental Ranking

Short-Term Technical PREMIUM

IBB Short-Term Technical Analysis

Who this matters to: The Short-Term Technical Ranking evaluates a stock’s trading over the past month. This is most useful for short- to medium-term stock and option traders.

Upgrade to Premium to unlock Short-Term Technical Ranking

Long-Term Technical PREMIUM

IBB Long-Term Technical Analysis

Who this matters to: The Long-Term Technical Ranking is a good gauge of how a stock has traded over the past several months. This is useful for medium to long-term stock and option traders.

Upgrade to Premium to unlock Long-Term Technical Ranking

Analyst Ranking PREMIUM

IBB Analyst Ranking

Who this matters to: Analyst Ranking shows you which stocks Wall Street analysts like the most. Since analysts build valuation models, this is most useful for medium to long-term investors who are interested in a valuation-based approach.

Upgrade to Premium to unlock Analyst Ranking Analysis

Valuation PREMIUM

IBB Valuation Ranking Analysis

Who this matters to: Valuation Ranking is most-useful for value-focused investors who plan to hold a stock for the long term.

Upgrade to Premium to unlock Valuation Ranking

Stock Sentiment PREMIUM

IBB Stock Sentiment Analysis

Who this matters to: Sentiment Rank looks at the past five trading days. This is our shortest-term evaluation and is best used by people with a very short horizon.

Upgrade to Premium to unlock Stock Sentiment Ranking

IBB Stock Analysis Overview

What this means: InvestorsObserver gives Nasdaq Biotechnology Ishares ETF (IBB) an overall rank of 38, which is below average. Nasdaq Biotechnology Ishares ETF is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. A rank of 38 means that 62% of stocks appear more favorable to our system.

Who this matters to: Overall Ranking is a comprehensive evaluation. It considers technical and fundamental factors and is a good starting point for evaluating a stock.

Create a FREE account to see full IBB report

IBB Fundamental Analysis

Who this matters to: The Fundamental Ranking considers the health of the underlying company. It is best used by longer-term buy-and-hold investors.

Upgrade to Premium to unlock Fundamental Ranking

IBB Short-Term Technical Analysis

Who this matters to: The Short-Term Technical Ranking evaluates a stock’s trading over the past month. This is most useful for short- to medium-term stock and option traders.

Upgrade to Premium to unlock Short-Term Technical Ranking

IBB Long-Term Technical Analysis

Who this matters to: The Long-Term Technical Ranking is a good gauge of how a stock has traded over the past several months. This is useful for medium to long-term stock and option traders.

Upgrade to Premium to unlock Long-Term Technical Ranking

IBB Analyst Ranking

Who this matters to: Analyst Ranking shows you which stocks Wall Street analysts like the most. Since analysts build valuation models, this is most useful for medium to long-term investors who are interested in a valuation-based approach.

Upgrade to Premium to unlock Analyst Ranking Analysis

IBB Valuation Ranking Analysis

Who this matters to: Valuation Ranking is most-useful for value-focused investors who plan to hold a stock for the long term.

Upgrade to Premium to unlock Valuation Ranking

IBB Stock Sentiment Analysis

Who this matters to: Sentiment Rank looks at the past five trading days. This is our shortest-term evaluation and is best used by people with a very short horizon.

Upgrade to Premium to unlock Stock Sentiment Ranking

Nasdaq Biotechnology Ishares ETF (IBB) Analyst Forecast

IBB Price, Volume, Earnings, and Dividend Date

  • Last Price $125.85
  • Previous Close $125.85
  • Change $0.00
  • Open $124.70
  • Volume 1,905,302
  • Avg. Volume (100-day) 1,743,111
  • Market Cap 7,878,210,000
  • Days Range 124.17 - 125.985
  • 52-week Range 104.29 - 138.74
  • Dividend Yield 0.33%
  • Ex. Dividend Date 12/13/22
  • P-E 16.2
  • EPS —
  • Earnings Date —
  • Sector —
  • Industry —
  • Avg. Analyst Rec. Premium
  • Beta 0.948
  • PEG Ratio —

Nasdaq Biotechnology Ishares ETF (IBB) Company Description

The investment seeks to track the investment results of the NYSE® FactSet® Global Genomics and Immuno Biopharma IndexTM. The fund generally will invest at least 80% of its assets in the component securities of the index and in investments that have economic characteristics that are substantially identical to the component securities of the index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents. The index is composed of developed and emerging market companies that could benefit from the long-term growth and innovation in genomics, immunology and bioengineering. -null-.

Nasdaq Biotechnology Ishares ETF (IBB) Stock Chart

View Interactive IBB chart

My Watchlists

Top Stocks